Aya Ogata

Dr. Aya Ogata

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AOAya Ogata
Aya Ogata
BJBin Ji
Bin Ji
TYTakashi Yamada
Takashi Yamada
SHSaori Hattori
Saori Hattori
JAJunichiro Abe
Junichiro Abe
YKYasuyuki Kimura
Yasuyuki Kimura

7 April 2025 in Plants
Verified
Journal Article
Open access
PDF file
HHHanane Horita
Hanane Horita
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
KOKenichi Ogata
Kenichi Ogata
AOAya Ogata
Aya Ogata
HKHisaka Kurita
Hisaka Kurita
HYHiroki Yoshioka
Hiroki Yoshioka
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show effectiveness against oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. Cell viability and G1 phase-related cell cycle markers were assessed by co-treatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.

13 May 2023 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AOAya Ogata
Aya Ogata
TYTakashi Yamada
Takashi Yamada
SHSaori Hattori
Saori Hattori
HIHiroshi Ikenuma
Hiroshi Ikenuma
JAJunichiro Abe
Junichiro Abe
YKYasuyuki Kimura
Yasuyuki Kimura

4 October 2023 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
AOAya Ogata
Aya Ogata
HIHiroshi Ikenuma
Hiroshi Ikenuma
JAJunichiro Abe
Junichiro Abe
TYTakashi Yamada
Takashi Yamada
SHSaori Hattori
Saori Hattori
YKYasuyuki Kimura
Yasuyuki Kimura

3 March 2023 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
KSKeiichi Suzuki
Keiichi Suzuki
HKHiroko Koyama
Hiroko Koyama
NNNarumasa Nakamura
Narumasa Nakamura
YKYasuyuki Kimura
Yasuyuki Kimura
AOAya Ogata
Aya Ogata
MSMasaaki Suzuki
Masaaki Suzuki

6 February 2025 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
HYHiroki Yoshioka
Hiroki Yoshioka
HHHanane Horita
Hanane Horita
YTYosuke Tsukiboshi
Yosuke Tsukiboshi
HKHisaka Kurita
Hisaka Kurita
AOAya Ogata
Aya Ogata
KOKenichi Ogata
Kenichi Ogata
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. Disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.